Stock Rating Upgrade
In recent days the Value Trend Rating for Surgery Partners Inc (NASDAQ: SGRY) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Surgery Partners Inc (NASDAQ: SGRY) stock declined by -2.7% on 1/10/25. The shares closed at $20.65. However, trading volume in this decline was exceptionally low at 42% of normal. The stock has been weak relative to the market over the last nine months and has declined -2.5% during the last week.
Current PriceTarget Research Rating
Surgery Partners has a current Value Trend Rating of C (Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Surgery Partners has a slightly positive Appreciation Score of 70 but a slightly negative Power Rating of 33, with the Neutral Value Trend Rating the result.
Be the first to comment